chr5-90674196-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_032119.4(ADGRV1):c.5072C>T(p.Thr1691Met) variant causes a missense change. The variant allele was found at a frequency of 0.000283 in 1,611,122 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00137 AC: 208AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000489 AC: 120AN: 245510Hom.: 1 AF XY: 0.000391 AC XY: 52AN XY: 133010
GnomAD4 exome AF: 0.000169 AC: 246AN: 1458838Hom.: 2 Cov.: 30 AF XY: 0.000145 AC XY: 105AN XY: 725458
GnomAD4 genome AF: 0.00138 AC: 210AN: 152284Hom.: 1 Cov.: 32 AF XY: 0.00130 AC XY: 97AN XY: 74462
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
- -
ADGRV1: BS2 -
- -
- -
not specified Benign:3
Variant summary: ADGRV1 c.5072C>T (p.Thr1691Met) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00028 in 1611122 control chromosomes, including 3 homozygotes, predominantly at a frequency of 0.0037 within the African or African-American subpopulation in the gnomAD database, suggesting that the variant is a benign polymorphism. To our knowledge, no occurrence of c.5072C>T in individuals affected with ADGRV1-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 227407). Based on the evidence outlined above, the variant was classified as likely benign. -
Thr1691Met in Exon 23 of GPR98: This variant is not expected to have clinical si gnificance because it has been identified in 0.3% (11/3156) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs146954342). -
- -
ADGRV1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at